to Content

Dr. Thomas GASSER Speaker and Group Leader, German Center for Neurodegenerative Diseases, Tübingen


1993-1996 Staff Physician, Dept. of Neurology, Klinikum Großhadern, University of Munich
1997-2002 Consultant, Dept. of Neurology, Klinikum Großhadern, University of Munich
1999 Assistant Professor of Neurology, Director, Molecular Neurogenetics Laboratory and Movement Disorders Outpatient Unit, Dept. of Neurology, University of Munich
2002 Director, Department of Neurodegenerative Disease and Professor of Neurology, Hertie-Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen
2009-2012 Speaker, German Center for Neurodegenerative Disease (DZNE), Tuebingen
2010 Dean for Research, Medical Faculty, University of Tuebingen
2013 Coordinator Clinical Studies, vicarious Speaker, German Center for Neurodegenerative diseases (DZNE),Tuebingen


Chairman, scientific advisory board of the Joint Programming Initiative on Neurodegenerative diseases
Coordinator, Parkinson-Network (NGFN-Plus) and Mefopa
Chairman, Scientific Issues Committee of the Movement Disorders Society
President, German Society for Neurogenetics


Zimprich A, et al., Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology, Neuron, 2004;44:1-20
Simon-Sanchez J,et al., Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nat Genet., 2009 Dec;41(12):1308-12
Brockmann K, et al., Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers, Mov Disord. 2011 Oct 11
Reinhardt P, et al., Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression, Cell stem cell, 2013 Mar 7;12(3):354-67


1985 Goedecke Research Award
1998 Parkinson Research Award of the German Society of Neurology
2010 Dingbauer Award of the German Society of Neurology
2011 K.J. Zülch Award of the Max-Planck Society